CL Quote, Financials, Valuation and Earnings

Church & Dwight has a net margin of 14.64% compared to Colgate-Palmolive's net margin of -4.97%. Colgate-Palmolive's return on equity of 434.96% beat Church & Dwight's return on equity of 13.41%.

Colgate-Palmolive has a consensus price target of --, signalling upside risk potential of 14.1%. On the other hand Church & Dwight has an analysts' consensus of -- which suggests that it could fall by -0.17%. Given that Colgate-Palmolive has higher upside potential than Church & Dwight, analysts believe Colgate-Palmolive is more attractive than Church & Dwight.

Colgate-Palmolive has a beta of 0.425, which suggesting that the stock is 57.48% less volatile than S&P 500. In comparison Church & Dwight has a beta of 0.574, suggesting its less volatile than the S&P 500 by 42.585%.

Colgate-Palmolive has a quarterly dividend of $0.50 per share corresponding to a yield of 2.15%. Church & Dwight offers a yield of 1.07% to investors and pays a quarterly dividend of $0.28 per share. Colgate-Palmolive pays 76.04% of its earnings as a dividend. Church & Dwight pays out 35.27% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Colgate-Palmolive quarterly revenues are $5B, which are larger than Church & Dwight quarterly revenues of $1.5B. Colgate-Palmolive's net income of $737M is higher than Church & Dwight's net income of -$75.1M. Notably, Colgate-Palmolive's price-to-earnings ratio is 26.37x while Church & Dwight's PE ratio is 47.58x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Colgate-Palmolive is 3.77x versus 4.32x for Church & Dwight. Usually stocks with elevated PS ratios are considered overvalued.

Clorox has a net margin of 14.64% compared to Colgate-Palmolive's net margin of 5.62%. Colgate-Palmolive's return on equity of 434.96% beat Clorox's return on equity of 135.23%.

Colgate-Palmolive has a consensus price target of --, signalling upside risk potential of 14.1%. On the other hand Clorox has an analysts' consensus of $146.86 which suggests that it could fall by -0.02%. Given that Colgate-Palmolive has higher upside potential than Clorox, analysts believe Colgate-Palmolive is more attractive than Clorox.

Colgate-Palmolive has a beta of 0.425, which suggesting that the stock is 57.48% less volatile than S&P 500. In comparison Clorox has a beta of 0.419, suggesting its less volatile than the S&P 500 by 58.102%.

Colgate-Palmolive has a quarterly dividend of $0.50 per share corresponding to a yield of 2.15%. Clorox offers a yield of 2.94% to investors and pays a quarterly dividend of $1.22 per share. Colgate-Palmolive pays 76.04% of its earnings as a dividend. Clorox pays out 212.5% of its earnings as a dividend. Colgate-Palmolive's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Clorox's is not.

Colgate-Palmolive quarterly revenues are $5B, which are larger than Clorox quarterly revenues of $1.8B. Colgate-Palmolive's net income of $737M is higher than Clorox's net income of $99M. Notably, Colgate-Palmolive's price-to-earnings ratio is 26.37x while Clorox's PE ratio is 57.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Colgate-Palmolive is 3.77x versus 2.74x for Clorox. Usually stocks with elevated PS ratios are considered overvalued.

Carmell has a net margin of 14.64% compared to Colgate-Palmolive's net margin of -14028.37%. Colgate-Palmolive's return on equity of 434.96% beat Carmell's return on equity of --.

Colgate-Palmolive has a consensus price target of --, signalling upside risk potential of 14.1%. On the other hand Carmell has an analysts' consensus of -- which suggests that it could fall by --. Given that Colgate-Palmolive has higher upside potential than Carmell, analysts believe Colgate-Palmolive is more attractive than Carmell.

Colgate-Palmolive has a beta of 0.425, which suggesting that the stock is 57.48% less volatile than S&P 500. In comparison Carmell has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Colgate-Palmolive has a quarterly dividend of $0.50 per share corresponding to a yield of 2.15%. Carmell offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Colgate-Palmolive pays 76.04% of its earnings as a dividend. Carmell pays out -- of its earnings as a dividend. Colgate-Palmolive's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Colgate-Palmolive quarterly revenues are $5B, which are larger than Carmell quarterly revenues of $20.5K. Colgate-Palmolive's net income of $737M is higher than Carmell's net income of -$2.9M. Notably, Colgate-Palmolive's price-to-earnings ratio is 26.37x while Carmell's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Colgate-Palmolive is 3.77x versus -- for Carmell. Usually stocks with elevated PS ratios are considered overvalued.

Procter & Gamble has a net margin of 14.64% compared to Colgate-Palmolive's net margin of 18.21%. Colgate-Palmolive's return on equity of 434.96% beat Procter & Gamble's return on equity of 28.65%.

Colgate-Palmolive has a consensus price target of --, signalling upside risk potential of 14.1%. On the other hand Procter & Gamble has an analysts' consensus of $181.07 which suggests that it could grow by 7.74%. Given that Colgate-Palmolive has higher upside potential than Procter & Gamble, analysts believe Colgate-Palmolive is more attractive than Procter & Gamble.

Colgate-Palmolive has a beta of 0.425, which suggesting that the stock is 57.48% less volatile than S&P 500. In comparison Procter & Gamble has a beta of 0.441, suggesting its less volatile than the S&P 500 by 55.862%.

Colgate-Palmolive has a quarterly dividend of $0.50 per share corresponding to a yield of 2.15%. Procter & Gamble offers a yield of 2.36% to investors and pays a quarterly dividend of $1.01 per share. Colgate-Palmolive pays 76.04% of its earnings as a dividend. Procter & Gamble pays out 62.59% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Colgate-Palmolive quarterly revenues are $5B, which are smaller than Procter & Gamble quarterly revenues of $21.7B. Colgate-Palmolive's net income of $737M is lower than Procter & Gamble's net income of $4B. Notably, Colgate-Palmolive's price-to-earnings ratio is 26.37x while Procter & Gamble's PE ratio is 28.98x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Colgate-Palmolive is 3.77x versus 4.95x for Procter & Gamble. Usually stocks with elevated PS ratios are considered overvalued.